One-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients-a pilot study

Basit Öğe Kaydı
dc.contributor.authorFriedmann, Anton
dc.contributor.authorWinkler, Marianna
dc.contributor.authorDiehl, Daniel
dc.contributor.authorYıldız, Mehmet Selim
dc.contributor.authorBilhan, Hakan
dc.date.accessioned2021-05-15T11:12:12Z
dc.date.available2021-05-15T11:12:12Z
dc.date.issued2021
dc.departmentDiş Hekimliği Fakültesien_US
dc.description.abstractObjectives The aim of the study was to compare the performance of narrow diameter implants in patients with uncontrolled diabetes mellitus type 2 (T2DM) and normo-glycemic individuals during the first 12 months after implant loading. Material and methods In 16 T2DM patients with HbA1C > 6.5% (test group) and 16 normo-glycemic patients (HbA1C < 6.0%; control group), one to two narrow diameter tissue level implants were placed in the posterior maxilla or mandible. After 3-month lasting integration period, implants were loaded by fixed dentures. The clinical parameters probing depth (PD), bleeding on probing (BOP), attachment loss (CAL), recession and papilla bleeding index (PBI) were assessed manually at loading and after 12 months of function. The paired digital periapical radiographs were analyzed with regard to the change in marginal bone level (MBL) from baseline to 12 months' control. The mean values calculated for both patient groups were statistically analyzed. The technical complications were recorded. Results The T2DM group accounted 13 patients due to 3 dropouts. The overall implant survival rate after 12 months was 100%. The differences in means for the clinical parameters and the MBL were statistically non-significant between the T2DM and normo-glycemic patients for the short period of loaded function reported here. No technical complications were recorded. Conclusions The study demonstrated an encouraging clinical outcome with narrow diameter implants in patients with uncontrolled T2DM compared to non-diabetics after 12 months post loading. For the short observation period, no biological and technical complications were reported regardless the glycemic status.en_US
dc.description.sponsorshipInstitut Straumann AG; Projekt DEALen_US
dc.description.sponsorshipOpen Access funding enabled and organized by Projekt DEAL. The study was supported by a restricted grant including the donation of the NDIs by the Institut Straumann AG.en_US
dc.identifier.doi10.1007/s00784-021-03957-x
dc.identifier.issn1432-6981
dc.identifier.issn1436-3771
dc.identifier.pmid33939006
dc.identifier.scopus2-s2.0-85105409192
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1007/s00784-021-03957-x
dc.identifier.urihttps://hdl.handle.net/20.500.12939/89
dc.identifier.wosWOS:000646496300001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorYıldız, Mehmet Selim
dc.language.isoen
dc.publisherSpringer Heidelbergen_US
dc.relation.ispartofClinical Oral Investigations
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMarginal bone lossen_US
dc.subjectType 2 Diabetes Mellitusen_US
dc.subjectNarrow Diameter Implantsen_US
dc.subjectSLActive Surfaceen_US
dc.subjectTiZr Implantsen_US
dc.titleOne-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients-a pilot study
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
s00784-021-03957-x.pdf
Boyut:
1.91 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Diş Hekimliği Fakültesi Yayın Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu